<DOC>
	<DOCNO>NCT01018966</DOCNO>
	<brief_summary>The purpose study determine DLT , MTD recommend Phase II dose ixabepilone Japanese patient solid tumor .</brief_summary>
	<brief_title>Study Ixabepilone ( BMS-247550 ) Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Epothilones</mesh_term>
	<criteria>20 year old Histologically cytologically confirm diagnosis adenocarcinoma Solid tumor Patients Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) â‰¥2</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>